| The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data RS Obach, JG Baxter, TE Liston, BM Silber, BC Jones, F Macintyre, ... Journal of Pharmacology and Experimental Therapeutics 283 (1), 46-58, 1997 | 1193 | 1997 |
| Controlled drug delivery: fundamentals and applications J Robinson, VHL Lee CRC Press, 1987 | 952 | 1987 |
| Stereoselective Disposition and Glucuronidation of Propranolol in Man BM Silber, NHG Holford Pharmacokinetics: A Modern View, 478-481, 1984 | 171 | 1984 |
| 2-Aminothiazoles as therapeutic leads for prion diseases A Gallardo-Godoy, J Gever, KL Fife, BM Silber, SB Prusiner, AR Renslo Journal of medicinal chemistry 54 (4), 1010-1021, 2011 | 159 | 2011 |
| Stereospecific assay for (-)-and (+)-propranolol in human and dog plasma. B Silber, S Riegelman Journal of Pharmacology and Experimental Therapeutics 215 (3), 643-648, 1980 | 132 | 1980 |
| Toward a 21st-Century Health Care System: Recommendations for Health Care Reform C Arrow, Auerbach, Bertko, Brownlee Annals of Internal Medicine 150 (7), 493-495, 2009 | 109 | 2009 |
| CYP2D6 genotyping as an alternative to phenotyping for determination of metabolic status in a clinical trial setting S McElroy, J Richmond, M Lira, D Friedman, BM Silber, PM Milos, ... AAPS pharmsci 2, 1-11, 2000 | 94 | 2000 |
| Liquid-chromatographic determination of five orally active cephalosporins--cefixime, cefaclor, cefadroxil, cephalexin, and cephradine--in human serum. JA Mcateer, MF Hiltke, BM Silber, RD Faulkner Clinical Chemistry 33 (10), 1788-1790, 1987 | 92 | 1987 |
| Absolute bioavailability of cefixime in man RD Faulkner, P Fernandez, G Lawrence, LL Sia, AJ Falkowski, AI Weiss, ... The Journal of Clinical Pharmacology 28 (8), 700-706, 1988 | 87 | 1988 |
| Pharmacokinetic profile of cefixime in man RD FAULKNER, A YACOBI, JS BARONE, SA KAPLAN, BM SILBER The Pediatric infectious disease journal 6 (10), 963-970, 1987 | 87 | 1987 |
| Determination of cefixime in biological samples by reversed-phase high-performance liquid chromatography AJ Falkowski, ZM Look, H Noguchi, BM Silber Journal of Chromatography B: Biomedical Sciences and Applications 422, 145-152, 1987 | 77 | 1987 |
| Driving drug discovery: the fundamental role of academic labs BM Silber Science translational medicine 2 (30), 30cm16-30cm16, 2010 | 75 | 2010 |
| Dose-dependent elimination of propranolol and its major metabolites in humans BM Silberx, NHG Holford, S Riegelman Journal of pharmaceutical sciences 72 (7), 725-732, 1983 | 60 | 1983 |
| An automated HPLC method for the assay of propranolol and its basic metabolites in plasma and urine MW Lo, B Silber, S Riegelman Journal of Chromatographic Science 20 (3), 126-131, 1982 | 56 | 1982 |
| Spironolactone-associated digoxin radioimmunoassay interference W Silber, B, Sheiner, LB, Powers, JL, Winter, ME Clin Chem 25 (1), 48-50, 1979 | 51 | 1979 |
| Different 2-aminothiazole therapeutics produce distinct patterns of scrapie prion neuropathology in mouse brains K Giles, DB Berry, C Condello, RC Hawley, A Gallardo-Godoy, C Bryant, ... Journal of Pharmacology and Experimental Therapeutics 355 (1), 2-12, 2015 | 50 | 2015 |
| Biaryl amides and hydrazones as therapeutics for prion disease in transgenic mice D Lu, K Giles, Z Li, S Rao, E Dolghih, JR Gever, M Geva, ML Elepano, ... Journal of Pharmacology and Experimental Therapeutics 347 (2), 325-338, 2013 | 50 | 2013 |
| Lack of gastrointestinal metabolism of propranolol in dogs after portacaval transposition. MW Lo, DJ Effeney, SM Pond, BM Silber, S Riegelman Journal of Pharmacology and Experimental Therapeutics 221 (2), 512-515, 1982 | 48 | 1982 |
| Pharmacokinetics of cefixime after once‐a‐day and twice‐a‐day dosing to steady state RD Faulkner, W Bohaychuk, RE Desjardins, ZM Look, JD Haynes, ... The Journal of Clinical Pharmacology 27 (10), 807-812, 1987 | 44 | 1987 |
| The pharmacokinetics of cefixime in the fasted and fed state RD Faulkner, W Bohaychuk, JD Haynes, RE Desjardins, A Yacobi, ... European journal of clinical pharmacology 34, 525-528, 1988 | 43 | 1988 |
